People · Operator
Named in public records as an officer, director or promoter · active 2013–2022 · Biotechnology, Other Technology, Other Health Care, Retailing
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Capricor Therapeutics, Inc. | — | Biotechnology | Series B | $51.9M | $147.2M | 2013 |
| Vision Path, Inc. | — | Other Technology | Series B | $26.5M | $304.6M | 2017 |
| Medpod Inc. | — | Other Health Care | Seed | $4.4M | $3.0M | 2015 |
| Baby Generation, Inc. | — | Retailing | Pre-Seed | $1.5M | $7.6M | 2017 |
| ReWoven, Inc. | — | Other Technology | Pre-Seed | $500K | $21.2M | 2017 |
Joshua Kazam at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Joshua Kazam on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jesse Horwitz | 3 | 5 |
| Benjamin Cogan | 3 | 4 |
| Rick Heitzmann | 2 | 11 |
| Joshua A. Kazam | 1 | 10 |
| Brian Levy | 1 | 8 |
| David M. Tanen | 1 | 8 |
| Arie S. Belldegrun | 1 | 5 |
| George Dunbar | 1 | 5 |
| Paul A. Mieyal | 1 | 4 |
| Frank Litvack | 1 | 3 |
| Pedro Granadillo | 1 | 3 |
| Daron Evans | 1 | 3 |
| Drew Tarlow | 1 | 3 |
| Gregory Schafer | 1 | 2 |
| Leland Gershell | 1 | 2 |
| Richard B. Brewer | 1 | 2 |
| Peter M. Kash | 1 | 2 |
| Hsiao D. Lieu | 1 | 2 |
| Andrew Hamer | 1 | 2 |
| Gregory W. Schafer | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.